⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

A

Agilent Technologies, Inc.

Healthcare · Diagnostics & Research

144.75USD

-2.1000 (-1.43%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY6.8B6.8B6.5B6.9B7.5B8.0B
Q11.7B1.8B1.7B1.7B1.8B1.9B
Q21.6B1.7B1.6B1.7B1.8B—
Q31.7B1.7B1.6B1.7B1.9B—
Q41.8B*1.7B*1.7B*1.9B*2.0B—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY4.184.194.434.576.206.76
Q1.9301.191.181.111.071.50
Q2.9101.021.05.7501.20—
Q31.10.380.9701.181.28—
Q41.23*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

1.60*
1.21*
1.52*
1.73
—